Astec LifeSciences Grants 1,142 Stock Options Under ESOP 2012 to Eligible Employee
Astec LifeSciences Limited's Nomination and Remuneration Committee approved the grant of 1,142 stock options under ESOP 2012 to an eligible employee at an exercise price of Rs.10/- per option. The options carry a 3-year vesting period with 1-month exercise window and comply with SEBI regulations.

*this image is generated using AI for illustrative purposes only.
Astec LifeSciences Limited has announced the grant of 1,142 stock options to an eligible employee under its Employee Stock Option Plan 2012 (ESOP 2012). The grant was approved by the company's Nomination and Remuneration Committee on April 30, 2026, in compliance with regulatory requirements.
Stock Option Grant Details
The company has provided comprehensive details regarding the stock option grant structure and terms:
| Parameter: | Details |
|---|---|
| Number of Options: | 1,142 stock options |
| Exercise Price: | Rs.10/- per option |
| Face Value per Share: | Rs.10/- |
| Vesting Period: | 3 years |
| Exercise Window: | 1 month from vesting date |
Each stock option entitles the holder to apply for one equity share of the company with a face value of Rs.10/-. The exercise price has been set at Rs.10/- per option, matching the face value of the underlying shares.
Regulatory Compliance and Framework
The stock option grant has been structured in accordance with multiple regulatory frameworks to ensure full compliance. The grant falls under the provisions of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. Additionally, the announcement has been made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Vesting and Exercise Terms
The granted options follow a structured vesting schedule designed to align employee interests with long-term company performance. The options will vest over a period of 3 years, providing a gradual release of benefits to the eligible employee. Once vested, the options must be exercised within 1 month from the date of vesting, though the Nomination and Remuneration Committee retains the authority to determine alternative exercise periods if deemed appropriate.
Corporate Communication and Documentation
Astec LifeSciences has ensured transparent communication of this development through multiple channels. The company has formally notified both BSE Limited and National Stock Exchange of India Limited about the stock option grant through official regulatory filing. The communication was signed by Tejashree Pradhan, Company Secretary & Compliance Officer, and the information has also been uploaded on the company's official website at www.godrejastec.com , ensuring accessibility for all stakeholders and maintaining compliance with disclosure requirements.
Historical Stock Returns for Astec Lifesciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.81% | -6.20% | +19.82% | +3.45% | +1.00% | -39.94% |
Will Astec LifeSciences expand its ESOP program to include more employees as part of a broader talent retention strategy?
How might this stock option grant signal the company's expectations for share price performance over the next three years?
Could this ESOP grant indicate upcoming organizational changes or key project assignments requiring enhanced employee commitment?


































